These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

838 related articles for article (PubMed ID: 31801546)

  • 21. Proteomics and cytokine analyses distinguish myalgic encephalomyelitis/chronic fatigue syndrome cases from controls.
    Giloteaux L; Li J; Hornig M; Lipkin WI; Ruppert D; Hanson MR
    J Transl Med; 2023 May; 21(1):322. PubMed ID: 37179299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytokine profiling of extracellular vesicles isolated from plasma in myalgic encephalomyelitis/chronic fatigue syndrome: a pilot study.
    Giloteaux L; O'Neal A; Castro-Marrero J; Levine SM; Hanson MR
    J Transl Med; 2020 Oct; 18(1):387. PubMed ID: 33046133
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of actin network proteins, talin-1 and filamin-A, in circulating extracellular vesicles as blood biomarkers for human myalgic encephalomyelitis/chronic fatigue syndrome.
    Eguchi A; Fukuda S; Kuratsune H; Nojima J; Nakatomi Y; Watanabe Y; Feldstein AE
    Brain Behav Immun; 2020 Feb; 84():106-114. PubMed ID: 31759091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of low-grade inflammation in ME/CFS (Myalgic Encephalomyelitis/Chronic Fatigue Syndrome) - associations with symptoms.
    Jonsjö MA; Olsson GL; Wicksell RK; Alving K; Holmström L; Andreasson A
    Psychoneuroendocrinology; 2020 Mar; 113():104578. PubMed ID: 31901625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Post-exertional symptoms distinguish Myalgic Encephalomyelitis/Chronic Fatigue Syndrome subjects from healthy controls.
    Mateo LJ; Chu L; Stevens S; Stevens J; Snell CR; Davenport T; VanNess JM
    Work; 2020; 66(2):265-275. PubMed ID: 32568143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vitamin D status in chronic fatigue syndrome/myalgic encephalomyelitis: a cohort study from the North-West of England.
    Earl KE; Sakellariou GK; Sinclair M; Fenech M; Croden F; Owens DJ; Tang J; Miller A; Lawton C; Dye L; Close GL; Fraser WD; McArdle A; Beadsworth MBJ
    BMJ Open; 2017 Nov; 7(11):e015296. PubMed ID: 29118054
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unravelling the nature of postexertional malaise in myalgic encephalomyelitis/chronic fatigue syndrome: the role of elastase, complement C4a and interleukin-1beta.
    Nijs J; Van Oosterwijck J; Meeus M; Lambrecht L; Metzger K; Frémont M; Paul L
    J Intern Med; 2010 Apr; 267(4):418-35. PubMed ID: 20433584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Defining the prevalence and symptom burden of those with self-reported severe chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME): a two-phase community pilot study in the North East of England.
    Strassheim VJ; Sunnquist M; Jason LA; Newton JL
    BMJ Open; 2018 Sep; 8(9):e020775. PubMed ID: 30232103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevated blood lactate in resting conditions correlate with post-exertional malaise severity in patients with Myalgic encephalomyelitis/Chronic fatigue syndrome.
    Ghali A; Lacout C; Ghali M; Gury A; Beucher AB; Lozac'h P; Lavigne C; Urbanski G
    Sci Rep; 2019 Dec; 9(1):18817. PubMed ID: 31827223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of chronic fatigue syndrome with premature telomere attrition.
    Rajeevan MS; Murray J; Oakley L; Lin JS; Unger ER
    J Transl Med; 2018 Feb; 16(1):44. PubMed ID: 29486769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bioenergetic and Proteomic Profiling of Immune Cells in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients: An Exploratory Study.
    Fernandez-Guerra P; Gonzalez-Ebsen AC; Boonen SE; Courraud J; Gregersen N; Mehlsen J; Palmfeldt J; Olsen RKJ; Brinth LS
    Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34209852
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A targeted genome association study examining transient receptor potential ion channels, acetylcholine receptors, and adrenergic receptors in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis.
    Johnston S; Staines D; Klein A; Marshall-Gradisnik S
    BMC Med Genet; 2016 Nov; 17(1):79. PubMed ID: 27835969
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Multimodal Magnetic Resonance Imaging Study on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Feasibility and Clinical Correlation.
    Kaur R; Greeley B; Ciok A; Mehta K; Tsai M; Robertson H; Debelic K; Zhang LX; Nelson T; Boulter T; Siu W; Nacul L; Song X
    Medicina (Kaunas); 2024 Aug; 60(8):. PubMed ID: 39202651
    [No Abstract]   [Full Text] [Related]  

  • 34. Review of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: an evidence-based approach to diagnosis and management by clinicians.
    Bested AC; Marshall LM
    Rev Environ Health; 2015; 30(4):223-49. PubMed ID: 26613325
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natural killer cytotoxicity in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): a multi-site clinical assessment of ME/CFS (MCAM) sub-study.
    Querec TD; Lin JS; Chen Y; Helton B; Kogelnik AM; Klimas NG; Peterson DL; Bateman L; Lapp C; Podell RN; Natelson BH; Unger ER;
    J Transl Med; 2023 Apr; 21(1):242. PubMed ID: 37013608
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Numeric Rating Scales Show Prolonged Post-exertional Symptoms After Orthostatic Testing of Adults With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    van Campen CLMC; Rowe PC; Verheugt FWA; Visser FC
    Front Med (Lausanne); 2020; 7():602894. PubMed ID: 33585505
    [No Abstract]   [Full Text] [Related]  

  • 37. Changes in DNA methylation profiles of myalgic encephalomyelitis/chronic fatigue syndrome patients reflect systemic dysfunctions.
    Helliwell AM; Sweetman EC; Stockwell PA; Edgar CD; Chatterjee A; Tate WP
    Clin Epigenetics; 2020 Nov; 12(1):167. PubMed ID: 33148325
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Role of Autonomic Function in Exercise-induced Endogenous Analgesia: A Case-control Study in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Healthy People.
    Oosterwijck JV; Marusic U; De Wandele I; Paul L; Meeus M; Moorkens G; Lambrecht L; Danneels L; Nijs J
    Pain Physician; 2017 Mar; 20(3):E389-E399. PubMed ID: 28339438
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel characterisation of mast cell phenotypes from peripheral blood mononuclear cells in chronic fatigue syndrome/myalgic encephalomyelitis patients.
    Nguyen T; Johnston S; Chacko A; Gibson D; Cepon J; Smith P; Staines D; Marshall-Gradisnik S
    Asian Pac J Allergy Immunol; 2017 Jun; 35(2):75-81. PubMed ID: 27362406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence of Clinical Pathology Abnormalities in People with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) from an Analytic Cross-Sectional Study.
    Nacul L; de Barros B; Kingdon CC; Cliff JM; Clark TG; Mudie K; Dockrell HM; Lacerda EM
    Diagnostics (Basel); 2019 Apr; 9(2):. PubMed ID: 30974900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.